TLR4 and atherosclerosis: The beneficial effect of inhibiting TLR4 on endothelium-dependent vasodilation has been described by our group and others in several models of hypertension (De Batista et al., 2014; Hernanz et al., 2015) and atherosclerosis (Chen et al., 2020).